辰光医疗
(920300)
| 流通市值：6.57亿 | | | 总市值：8.48亿 |
| 流通股本：6653.17万 | | | 总股本：8584.71万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 47,964,311.53 | 24,678,348.47 | 89,939,697.09 | 67,742,641.82 |
| 营业总成本 | 66,351,141.36 | 32,480,379.43 | 129,182,046.1 | 96,144,924.52 |
| 其他经营收益 | | | | |
| 营业利润 | -14,229,275.87 | -7,350,518.6 | -51,281,266.54 | -25,454,232.71 |
| 利润总额 | -14,180,786.75 | -7,304,305.55 | -51,677,914.53 | -25,424,367.88 |
| 净利润 | -12,911,802.9 | -7,275,950.67 | -60,440,038.14 | -19,330,668.35 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -12,911,802.9 | -7,275,950.67 | -60,440,038.14 | -19,330,668.35 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 164,694,164.82 | 182,717,533.28 | 185,839,019.83 | 217,400,538.69 |
| 非流动资产: | | | | |
| 非流动资产合计 | 154,218,262.15 | 158,039,890.29 | 163,144,632.3 | 187,806,841.12 |
| 资产总计 | 318,912,426.97 | 340,757,423.57 | 348,983,652.13 | 405,207,379.81 |
| 流动负债: | | | | |
| 流动负债合计 | 113,204,639.35 | 125,145,620.39 | 125,130,129.59 | 165,925,017.03 |
| 非流动负债: | | | | |
| 非流动负债合计 | 50,977,775.58 | 55,245,938.91 | 56,211,707.6 | 30,531,178.05 |
| 负债合计 | 164,182,414.93 | 180,391,559.3 | 181,341,837.19 | 196,456,195.08 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 154,730,012.04 | 160,365,864.27 | 167,641,814.94 | 208,751,184.73 |
| 股东权益合计 | 154,730,012.04 | 160,365,864.27 | 167,641,814.94 | 208,751,184.73 |
| 负债和股东权益合计 | 318,912,426.97 | 340,757,423.57 | 348,983,652.13 | 405,207,379.81 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 52,031,596.7 | 27,314,152.66 | 125,272,710.5 | 101,369,093.91 |
| 经营活动现金流出小计 | 50,346,679.03 | 23,777,673.1 | 123,340,838.18 | 92,740,855.92 |
| 经营活动产生的现金流量净额 | 1,684,917.67 | 3,536,479.56 | 1,931,872.32 | 8,628,237.99 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 10,832,547.95 | 770,000 | 98,253,733.24 | 88,239,046.87 |
| 投资活动现金流出小计 | 11,543,178.64 | 11,074,047.01 | 106,151,694.02 | 89,845,836.59 |
| 投资活动产生的现金流量净额 | -710,630.69 | -10,304,047.01 | -7,897,960.78 | -1,606,789.72 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 42,000,000 | 14,000,000 | 191,600,000 | 96,000,000 |
| 筹资活动现金流出小计 | 65,124,133.5 | 20,057,625.26 | 209,361,707.58 | 105,803,939.59 |
| 筹资活动产生的现金流量净额 | -23,124,133.5 | -6,057,625.26 | -17,761,707.58 | -9,803,939.59 |
| 汇率变动对现金及现金等价物的影响 | -74,488.94 | -45,012.43 | -33,536.46 | 16,681.48 |
| 现金及现金等价物净增加额 | -22,224,335.46 | -12,870,205.14 | -23,761,332.5 | -2,765,809.84 |
| 期末现金及现金等价物余额 | 6,543,343.39 | 15,897,473.71 | 28,767,678.85 | 49,763,201.51 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -22,224,335.46 | - | -23,761,332.5 | - |